Analysts at StockNews.com started coverage on shares of Mannatech (NASDAQ:MTEX – Get Free Report) in a report issued on Saturday. The firm set a “buy” rating on the stock.
Mannatech Stock Performance
MTEX opened at $11.00 on Friday. The company has a quick ratio of 0.74, a current ratio of 1.25 and a debt-to-equity ratio of 0.44. The firm has a market cap of $20.74 million, a PE ratio of -13.58 and a beta of 1.18. The business has a fifty day simple moving average of $9.28 and a 200-day simple moving average of $8.05. Mannatech has a fifty-two week low of $6.75 and a fifty-two week high of $13.00.
Mannatech (NASDAQ:MTEX – Get Free Report) last released its quarterly earnings results on Tuesday, November 12th. The company reported ($0.17) earnings per share for the quarter. The company had revenue of $31.73 million during the quarter. Mannatech had a negative net margin of 1.26% and a negative return on equity of 15.62%.
About Mannatech
Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.
Featured Stories
- Five stocks we like better than Mannatech
- The 3 Best Retail Stocks to Shop for in August
- Power Up: Gaming Industry Expansion Fuels Stock Opportunities
- Short Selling: How to Short a Stock
- These 3 Quirky ETFs May Be Strong Plays in 2025
- Quiet Period Expirations Explained
- Buffett Takes the Bait; Berkshire Buys More Oxy in December
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
